Advertisement

Archives of Sexual Behavior

, Volume 40, Issue 3, pp 597–606 | Cite as

Recreational Use of Erectile Dysfunction Medications in Undergraduate Men in the United States: Characteristics and Associated Risk Factors

  • Christopher B. Harte
  • Cindy M. MestonEmail author
Original Paper

Abstract

Mounting evidence indicates that erectile dysfunction medications (EDMs) have become increasingly used as a sexual enhancement aid among men without a medical indication. Recreational EDM use has been associated with increased sexual risk behaviors, an increased risk for STIs, including incident HIV infection, and high rates of concomitant illicit drug use. The aim of the present study was to investigate the characteristics and associated risk factors for recreational EDM use among young, healthy, undergraduate men. A cross-sectional sample of 1,944 men were recruited from 497 undergraduate institutions within the Unites States between January 2006 and May 2007. The survey assessed patterns of EDM use, as well as demographic, substance use, and sexual behavior characteristics. Four percent of participants had recreationally used an EDM at some point in their lives, with 1.4% reporting current use. The majority of recreational EDM users reported mixing EDMs with illicit drugs and particularly during risky sexual behaviors. Recreational EDM use was independently associated with increased age, gay, or bisexual sexual orientation, drug abuse, lifetime number of sex partners, and lifetime number of “one-night stands.” Recreational EDM users also reported a 2.5-fold rate of erectile difficulties compared to nonusers. Overall, recreational use of EDMs was associated with sexual risk behaviors and substance abuse; however, a relatively small proportion of undergraduates reported using EDMs. Results also suggest that a sizable portion of recreational EDM users are heterosexual men, and that use does not solely occur within the environments of venues that cater to men having sex with men.

Keywords

Erectile dysfunction medication Sildenafil Drug abuse Sexual risk Sexual behavior 

Notes

Acknowledgments

This study was supported by Grant 5 RO1 AT00224-02 from the National Center for Complementary and Alternative Medicine to Cindy Meston. The NCCAM had no further role in study design; in the collection, analysis, and interpretation of data; in preparation and the writing of the report; or in the decision to submit the paper for publication. The authors thank Alison Marks for help with online data management and data acquisition.

References

  1. Benotsch, E. G., Seeley, S., Mikytuck, J. J., Pinkerton, S. D., Nettles, C. D., & Ragsdale, K. (2006). Substance use, medications for sexual facilitation, and sexual risk behavior among traveling men who have sex with men. Sexually Transmitted Diseases, 33, 706–711.PubMedCrossRefGoogle Scholar
  2. Cachey, E., Mar-Tang, M., & Mathews, W. (2004). Screening for potentially transmitting sexual risk behaviors, urethral sexually transmitted infection, and sildenafil use among males entering care for HIV infection. AIDS Patient Care and STDs, 18, 349–354.CrossRefGoogle Scholar
  3. Cappelleri, J. C., Rosen, R. C., Smith, M. D., Mishra, A., & Osterloh, I. H. (1999). Diagnostic evaluation of the erectile function domain of the International Index of Erectile Function. Urology, 54, 346–351.PubMedCrossRefGoogle Scholar
  4. Chu, P. L., McFarland, W., Gibson, S., Weide, D., Henne, J., Miller, P., et al. (2003). Viagra use in a community-recruited sample of men who have sex with men, San Francisco. Journal of Acquired Immune Deficiency Syndromes, 33, 191–193.PubMedCrossRefGoogle Scholar
  5. Colfax, G., Mansergh, G., Guzman, R., Vittinghoff, E., Marks, G., Rader, M., et al. (2001). Drug use and sexual risk behavior among gay and bisexual men who attend circuit parties: A venue-based comparison. Journal of Acquired Immune Deficiency Syndromes, 28, 373–379.PubMedGoogle Scholar
  6. Cooper, M. L. (2002). Alcohol use and risky sexual behavior among college students and youth: Evaluating the evidence. Journal of Studies on Alcohol Supplement, 14, 101–117.PubMedGoogle Scholar
  7. de Freitas, V. M., de Menezes, F. G., Antonialli, M. M., & Nascimento, J. W. (2008). Use of phosphodiesterase-5 inhibitors by college students. Revista de Saude Publica, 42, 965–967.PubMedCrossRefGoogle Scholar
  8. Delate, T., Simmons, V. A., & Motheral, B. R. (2004). Patterns of use of sildenafil among commercially insured adults in the United States: 1998–2002. International Journal of Impotence Research, 16, 313–318.PubMedCrossRefGoogle Scholar
  9. Fisher, D. G., Malow, R., Rosenberg, R., Reynolds, G., Farrell, N., & Jaffe, A. (2006). Recreational Viagra use and sexual risk among drug abusing men. American Journal of Infectious Diseases, 2, 107–114.PubMedCrossRefGoogle Scholar
  10. Gledhill-Hoyt, J., Lee, H., Strote, J., & Wechsler, H. (2000). Increased use of marijuana and other illicit drugs at US colleges in the 1990s: Results of three national surveys. Addiction, 95, 1655–1667.PubMedCrossRefGoogle Scholar
  11. Goldstein, I., Lue, T. F., Padma-Nathan, H., Rosen, R. C., Steers, W. D., & Wicker, P. A. (1998). Oral sildenafil in the treatment of erectile dysfunction. New England Journal of Medicine, 338, 1397–1404.PubMedCrossRefGoogle Scholar
  12. Hirshfield, S., Remien, R. H., Humberstone, M., Walavalkar, I., & Chiasson, M. A. (2004). Substance use and high-risk sex among men who have sex with men: A national online survey. AIDS Care, 16, 1036–1047.PubMedCrossRefGoogle Scholar
  13. Ishikura, F., Beppu, S., Hamada, T., Khandheria, B. K., Seward, J. B., & Nehra, A. (2000). Effects of sildenafil citrate (Viagra) combined with nitrate on the heart. Circulation, 102, 2516–2521.PubMedGoogle Scholar
  14. Jackson, G. (2005). PDE 5 inhibitors and HIV risk: Current concepts and controversies. International Journal of Clinical Practice, 59, 1247–1252.PubMedCrossRefGoogle Scholar
  15. Kim, A. A., Kent, C. K., & Klausner, J. D. (2002). Increased risk of HIV and sexually transmitted disease transmission among gay or bisexual men who use Viagra, San Francisco 2000–2001. AIDS, 16, 1425–1428.PubMedCrossRefGoogle Scholar
  16. Kinsey, A. C., Pomeroy, W. B., & Martin, C. E. (1948). Sexual behavior in the human male. Philadelphia, PA: W. B. Saunders.Google Scholar
  17. Korkes, F., Costa-Matos, A., Gasperini, R., Reginato, P. V., & Perez, M. D. (2008). Recreational use of PDE5 inhibitors by young healthy men: Recognizing this issue among medical students. Journal of Sexual Medicine, 5, 2414–2418.PubMedGoogle Scholar
  18. Laumann, E. O., Paik, A., & Rosen, R. C. (1999). Sexual dysfunction in the United States: Prevalence and predictors. Journal of the American Medical Association, 281, 537–544.PubMedCrossRefGoogle Scholar
  19. Loeb, L. (2004). Viagra: The science and politics of drugs, sex, and risk. Focus, 19, 4–7.PubMedGoogle Scholar
  20. McCambridge, J., Mitcheson, L., Hunt, N., & Winstock, A. (2006). The rise of Viagra among British illicit drug users: 5-year survey data. Drug and Alcohol Review, 25, 111–113.PubMedCrossRefGoogle Scholar
  21. Mondaini, N., Ponchietti, R., Muir, G. H., Montorsi, F., Di Loro, F., Lombardi, G., et al. (2003). Sildenafil does not improve sexual function in men without erectile dysfunction but does reduce the postorgasmic refractory time. International Journal of Impotence Research, 15, 225–228.PubMedCrossRefGoogle Scholar
  22. Musacchio, N. S., Hartrich, M., & Garofalo, R. (2006). Erectile dysfunction and Viagra use: What’s up with college-age males? Journal of Adolescent Health, 39, 452–454.PubMedCrossRefGoogle Scholar
  23. Rosen, R. C., Cappelleri, J. C., Smith, M. D., Lipsky, J., & Pena, B. M. (1999). Development and evaluation of an abridged, 5-item version of the International Index of Erectile Function (IIEF-5) as a diagnostic tool for erectile dysfunction. International Journal of Impotence Research, 11, 319–326.PubMedCrossRefGoogle Scholar
  24. Rosen, R. C., & Kostis, J. B. (2003). Overview of phosphodiesterase 5 inhibition in erectile dysfunction. American Journal of Cardiology, 92(Suppl. 9A), 9M–15M.PubMedCrossRefGoogle Scholar
  25. Rosen, R. C., Riley, A., Wagner, G., Osterloh, I. H., Kirkpatrick, J., & Mishra, A. (1997). The international index of erectile function (IIEF): A multidimensional scale for assessment of erectile dysfunction. Urology, 49, 822–830.PubMedCrossRefGoogle Scholar
  26. Santtila, P., Sandnabba, N., Jern, P., Varjonen, M., Witting, K., & von der Pahlen, B. (2007). Recreational use of erectile dysfunction medication may decrease confidence in ability to gain and hold erections in young males. International Journal of Impotence Research, 19, 591–596.PubMedCrossRefGoogle Scholar
  27. Selvin, E., Burnett, E., & Platz, E. (2007). Prevalence and risk factors for erectile dysfunction in the U.S. American Journal of Medicine, 120, 151–157.PubMedCrossRefGoogle Scholar
  28. Sherr, L., Bolding, G., Maguire, M., & Elford, J. (2000). Viagra use and sexual risk behavior among gay men in London. AIDS, 14, 2051–2053.PubMedCrossRefGoogle Scholar
  29. Swearingen, S. G., & Klausner, J. D. (2005). Sildenafil use, sexual risk behavior, and risk for sexually transmitted diseases, including HIV infection. American Journal of Medicine, 118, 571–577.PubMedCrossRefGoogle Scholar
  30. U.S. Bureau of the Census. (2000). Native resident population estimates of the United States by sex, race, and Hispanic origin: April 1, 1990 to July 1, 1999. Washington, DC: Author. Retrieved February 5, 2010, from http://www.census.gov/population/estimates/nation/nativity/nbtab003.txt.
  31. Wiederman, M. W. (1999). Volunteer bias in sexuality research using college student participants. Journal of Sex Research, 36, 59–66.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2010

Authors and Affiliations

  1. 1.Department of PsychologyUniversity of Texas at AustinAustinUSA

Personalised recommendations